An announcement from Cardlytics ( (CDLX) ) is now available.
Cardlytics, Inc. announced that Bank of America has issued a non-renewal notice for their existing agreements, set to expire on July 31, 2025, with operations continuing until January 27, 2026. Despite the non-renewal, Cardlytics believes the impact on its financial results will be minimal due to potential new arrangements with Bank of America and growth from other financial partners. Additionally, Cardlytics amended its loan facility with Banc of California, extending the maturity date to April 15, 2028, while maintaining $60 million in unused borrowings.
Spark’s Take on CDLX Stock
According to Spark, TipRanks’ AI Analyst, CDLX is a Neutral.
Cardlytics’ overall stock score is low due to significant financial performance issues, including declining revenues and high leverage, compounded by weak technical indicators and poor valuation. Although the earnings call suggested potential for future improvements, current challenges overshadow these prospects, leading to a cautious outlook.
To see Spark’s full report on CDLX stock, click here.
More about Cardlytics
Cardlytics, Inc. operates in the financial technology industry, providing a platform that publishes offers to customers of financial institutions, leveraging partnerships with banks like Bank of America to deliver targeted marketing solutions.
YTD Price Performance: -59.52%
Average Trading Volume: 1,016,542
Technical Sentiment Signal: Buy
Current Market Cap: $78.78M
Find detailed analytics on CDLX stock on TipRanks’ Stock Analysis page.